Price is syncing
Reported smart-money activity is still available below.
1 month
+2.0%
price return
Year to date
-2.1%
price return
Recent earnings
4/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
32 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage is bullish
22 bullish · 8 neutral · 2 bearish
Tone of tracked coverage
Neurocrine Biosciences Inc (NBIX) Shareholder Structure: Major Shareholders & Institutional Holdings
NeutralJul 24Neurocrine Hires Market Access Chief, Promotes Two Executives
BullishJul 24Neurocrine Biosciences names three senior vice presidents By Investing.com
Leans bullishJul 23Neurocrine Biosciences names three senior vice presidents By Investing.com
BullishJul 23Neurocrine Biosciences Announces Key Leadership Hiring, Promotions
Leans bullishJul 23Neurocrine Biosciences (NBIX) Stock Trades Fair On Earnings But Mixed On Value
NeutralJul 23NBIX: Neurocrine Biosciences, Inc. Latest Stock Price, Analysis, News and Trading Ideas
NeutralJul 23Neurocrine Biosciences (NBIX) Appoints Samir Siddhanti To Lead Growth After $2.9 Billion Deal
NeutralJul 22BlackRock
Q1 2026 13F
$1.8B
position
AlphaYou
